Does low luteal progesterone relative to estrogen cause premenstrual breast tenderness and anxiety?

The hormonal dynamics of the luteal phase—specifically the balance between estrogen and progesterone—play a critical role in the pathophysiology of premenstrual syndrome (PMS). Research indicates that a high estrogen-to-progesterone (E2/P) ratio, often referred to as estrogen dominance, is a primary driver of physical and psychological symptoms.

Clinical and physiological findings

• Breast Tenderness (Mastalgia): Clinical evidence links a high E2/P ratio to increased premenstrual breast pain and cyst enlargement. Progesterone normally counterbalances estrogen’s effects; when it is relatively low, breast tissue exhibits heightened responsiveness, leading to the cyclic discomfort common in the 41-year-old demographic.
• Anxiety and Mood: The relationship between low progesterone and anxiety is mediated by its neuroactive metabolites. Progesterone is converted to allopregnanolone, which stabilizes mood by modulating GABA_A receptors. Low luteal levels disrupt this calming effect, contributing to increased irritability and restlessness.

Mechanistic explanations

• Capillary Permeability: Estrogen upregulates Vascular Endothelial Growth Factor (VEGF), which increases capillary permeability. Progesterone typically opposes this action. In the absence of sufficient progesterone, fluid escapes from the capillaries into the breast tissue (extravasation), resulting in painful engorgement and edema.
• Fluid Regulation (RAAS): Estrogen stimulates the renin-angiotensin-aldosterone system (RAAS), which promotes sodium and water retention. Progesterone possesses anti-mineralocorticoid properties that inhibit aldosterone binding. A low progesterone state fails to neutralize estrogen-driven RAAS activation, leading to systemic and localized fluid retention.

Bottom line

The claim is well-supported: low luteal progesterone relative to estrogen increases breast tissue responsiveness and fluid retention via unopposed VEGF and RAAS activity, while simultaneously contributing to anxiety through reduced GABAergic modulation.